Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001787792-25-000005
Filing Date
2025-06-13
Accepted
2025-06-13 11:10:42
Documents
1
Effectiveness Date
2025-06-13
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6536
  Complete submission text file 0001787792-25-000005.txt   7722
Mailing Address 630 FLUSHING AVENUE, BOX 104 BROOKLYN NY 11206
Business Address 515 MADISON AVENUE NEW YORK NY 10022 917-930-4332
Fisher Wallace Laboratories, Inc. (Filer) CIK: 0001787792 (see all company filings)

EIN.: 208131183 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-548894 | Film No.: 251045159
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)